Chris Boshoff,Marshall Posner
Chris Boshoff
Sandra Buckner
Sandra Buckner
Fattaneh A Tavassoli,Donald R Lannin
Fattaneh A Tavassoli
Effect of bisphosphonates on pain and quality of life in patients with bone metastases [0.03%]
双膦酸盐对骨转移患者疼痛和生活质量的影响
Luis Costa,Pierre P Major
Luis Costa
Bone is the most common organ for tumor metastasis, especially in patients with cancers of the breast or prostate. Bone metastases disrupt skeletal metabolism and result in considerable skeletal morbidity, including intractable, chronic bon...
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors [0.03%]
神经内分泌肿瘤患者的晚期疾病治疗
Diane L Reidy,Laura H Tang,Leonard B Saltz
Diane L Reidy
Well-differentiated neuroendocrine tumors (NETs), which are also referred to as well-differentiated endocrine carcinoma according to WHO terminology, are usually slow-growing cancers, even when they exhibit gross local invasion and/or metas...
Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck [0.03%]
治疗头部和颈部鳞状细胞癌患者的西妥昔单抗疗法
William N William Jr,Edward S Kim,Roy S Herbst
William N William Jr
We discuss the results of the phase III EXTREME (Erbitux in First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer) trial. In this study, 442 untreated patients with advanced squamous cell carcinomas of the head and neck (SCCH...
Vincent T DeVita Jr
Vincent T DeVita Jr
Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer' [0.03%]
对“间歇性雄激素阻断治疗应视为前列腺癌的标准疗法”的回应
Nicolas André,Eddy Pasquier
Nicolas André
Pharmacogenomic progress in individualized dosing of key drugs for cancer patients [0.03%]
癌症患者个体化治疗的关键药物的药理基因组学进展
Christine M Walko,Howard McLeod
Christine M Walko
Determining the correct dosage for the majority of traditional chemotherapeutic agents presents a challenge because most drugs have a narrow therapeutic index, which results in a fine balance between doses that cause significant drug toxici...
Xoft Axxent electronic brachytherapy: a new device for delivering brachytherapy to the breast [0.03%]
用于乳腺插植放射治疗的新设备:Xoft Axxent电子近距离放射装置
Adam Dickler
Adam Dickler
Balloon-based brachytherapy was developed to simplify the brachytherapy technique and make accelerated partial breast irradiation more accessible to patients with breast cancer who are suitable candidates for this technique. Xoft Axxent (Xo...